$BNTX $PFE Amazing earnings report from Pfizer! Why would anyone sell under $200 biontech shares... looking at analysts projections of 1.9 billion revenue... the REAL numbers show close to 4 billion for Biontech. If analysts say now $125+ then the actual share price is $250. I feel bad scalping the fearful investors all morning, but you think foolish you pay the price. This will close higher than $190 today and will be right back above $200. Trust tsunami this is a $250 plus stock.
6
6 Likes